Longeveron Appoints Than Powell as CBO and Hits Clinical Trial Milestones in HLHS Program
Longeveron Inc. has appointed Than Powell as Chief Business Officer and announced significant progress in its clinical trials, including completion of enrollment in a pivotal Phase 2b trial for its HLHS treatment.
2 minutes to read
